Importer of Controlled Substances; Notice of Application, 34152 [05-11639]

Download as PDF 34152 Federal Register / Vol. 70, No. 112 / Monday, June 13, 2005 / Notices development activities are: developing and promoting voluntary consensus standards for Polyurea Elastomeric Coating/Lining Systems and Polyurea Elastomeric Joint Sealant/Filler Systems. Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 05–11598 Filed 6–10–05; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a registration under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on April 27, 2005, Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in Schedule II. The company plans to import the listed controlled substance to bulk manufacturer amphetamine. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, D.C. 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, VerDate jul<14>2003 16:45 Jun 10, 2005 Jkt 205001 Alexandria, Virginia 22301; and must be filed no later than July 13, 2005. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substance listed in Schedule I or II are, and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. Dated: June 6, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–11639 Filed 6–10–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Employment and Training Administration [TA–W–56,992] Bosch-Rexroth Corporation; Mobile Hydraulics Division Wooster, OH; Notice of Termination of Investigation Pursuant to Section 221 of the Trade Act of 1974, an investigation was initiated on April 18, 2005 in response to petition filed by the United Automobile, Aerospace, Agricultural Implement Workers of America, Local 1239 on behalf of workers at BoschRexroth Corporation, Mobile Hydraulics Division, Wooster, Ohio. The petitioner has requested that the petition be withdrawn. Consequently, the investigation has been terminated. Signed in Washington, DC, this 1st day of June, 2005. Elliott S. Kushner, Certifying Officer, Division of Trade Adjustment Assistance. [FR Doc. E5–3038 Filed 6–10–05; 8:45 am] BILLING CODE 4510–30–P DEPARTMENT OF JUSTICE DEPARTMENT OF LABOR Foreign Claims Settlement Commission Employment and Training Administration [F.C.S.C. Meeting Notice No. 3–05] [TA–W–55,607; TA–W–55,607A] Sunshine Act Meeting Creo Americas, Inc., U.S. Headquarters; A Subsidiary of Creo, Inc., Billerica, MA; Including an Employee of Creo Americas, Inc., U.S. Headquarters; A Subsidiary of Creo, Inc., Billerica, MA, Located in New York, NY; Amended Notice of Revised Determination on Remand The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR Part 504) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of meetings for the transaction of Commission business and other matters specified, as follows: Date and Time: Thursday, June 23, 2005, at 11 a.m. Subject Matter: Issuance of Proposed Decisions in claims against Albania. Status: Open. All meetings are held at the Foreign claims Settlement Commission, 600 E Street, NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, may be directed to: Administrative Officer, Foreign Claims Settlement Commission, 600 E Street, NW., Room 6002, Washington, DC 20579. Telephone: (202) 616–6988. Mauricio J. Tamargo, Chairman. [FR Doc. 05–11752 Filed 6–9–05; 3:10 pm] BILLING CODE 4410–01–P PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 In accordance with Section 223 of the Trade Act of 1974 (19 U.S.C. 2273) the Department of Labor issued a Revised Determination on Remand on April 5, 2005, applicable to workers of Creo Americas, Inc., U.S. Headquarters, a subsidiary of Creo, Inc., Billerica, Massachusetts. The notice was published in the Federal Register on April 25, 2005 (70 FR 21247). At the request of the State agency, the Department reviewed the certification for workers of the subject firm. New information shows that a worker separation occurred involving an employee of the Billerica, Massachusetts facility of Creo Americas, Inc., U.S. Headquarters, a subsidiary of Creo, Inc., located in New York, New York. Mr. Amnon Zerahia provided technical support for the production of professional imaging and software production at the West Virginia and E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 70, Number 112 (Monday, June 13, 2005)]
[Notices]
[Page 34152]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11639]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
registration under 21 U.S.C. 952(a)(2)(B) authorizing the importation 
of such a substance, provide manufacturers holding registrations for 
the bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on April 27, 2005, Boehringer Ingelheim Chemicals, Inc., 2820 N. 
Normandy Drive, Petersburg, Virginia 23805, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of Phenylacetone (8501), a basic class of controlled substance 
listed in Schedule II.
    The company plans to import the listed controlled substance to bulk 
manufacturer amphetamine.
    Any manufacturer who is presently, or is applying to be, registered 
with DEA to manufacture such basic classes of controlled substances may 
file comments or objections to the issuance of the proposed 
registration and may, at the same time, file a written request for a 
hearing on such application pursuant to 21 CFR 1301.43 and in such form 
as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than July 13, 2005.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic class of any controlled substance listed 
in Schedule I or II are, and will continue to be required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: June 6, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-11639 Filed 6-10-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.